A randomized, multi-center, double-blind, placebo-controlled, parallel-group, dose-ranging safety, efficacy, and tolerability study of two doses of epinastine nasal spray (0.05% and 0.1%) vs. placebo in subjects with seasonal allergic rhinitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this trial is to determine the safety, efficacy and tolerability of two doses of the study drug compared to placebo for the treatment of subjects with seasonal allergic rhinitis.
Epistemonikos ID: 154630baebc6083b0190c3df7d81a7c351ca26a3
First added on: May 04, 2024